↑  Read the latest from the desks  ·  fresh intelligence, published daily✦Quiet reading✦No ads, ever

✦Corporate brand & media services✦Made in Virginia Beach since 1997✦

Astrotech: Old boat (three warning signs)Old boat

Astrotech $ASTC

Saw revenue fall 13.0% in FY2026 to $1 million, operating margin -1549% against a -1.0% median for laboratory analytical instruments, equity 78.9% of assets.

Last filing10-Q, 13 Nov 2026

Next year, 80%$0M–$2M
Growth, on the year−13.0%
Operating margin−1548.5%
Equity of assets78.9%
Credibility63%
Track record5 of 12
Your call, sealedNext year’s revenue, your range. Sealed now, graded when the annual report lands.
Edgarette’s full reading · exposure, experience, soundness, credibility, range

🫧 Edgar looked up ASTROTECH Corp ($ASTC). Last filing: 10-Q, 2026-11-13. 10 event filings (8-K) in the past twelve months.

🔖 Exposure: revenue $913K (FY2026). Experience: revenue down 13.0% on the year, up 1.2% a year over 4 years; operating margin -1548.5%, down from -1404.6%. Soundness: equity 78.9% of assets, return on equity -89.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $314K and $2.4M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $273K to $2.8M. A statistical range, not company guidance. Against peers (12 filers, $50M+ revenue, laboratory analytical instruments): operating margin -1548.5% against a -1.0% median; growth -13.0% against 1.1%.

Read from its own SEC filings · nothing written, nothing inferred

ASTROTECH Corp against its own record and its peers
Operating marginPeer median -1.0%-1548.5%Revenue, on the yearPeer median 1.1%-13.0%Equity of assetsPeer median 53.9%78.9%Return on equityPeer median -2.9%-89.2%Gold tick: the median of 12–13 peers with $50M+ revenue in laboratory analytical instruments

Speed and cash · fiscal 2025

Cash Compass🌊 In between · no clear cash pattern yet
Inside viewTurns -200.0% of revenue into operating cash; revenue growing 6.5% a year over three years; no common dividend.
Outside viewAmong under $50M companies: 1st percentile for cash, 59th for growth. cash growth

Both views must agree for a label · a description, not advice.

Cash flow (op · inv · fin · free)−$13M · $12M · $7M · −$14M
Investment book (cash · short · long)$8M · $3M · $0M · current ratio 7.06 · unrealized −$0M
Revenue swing · equity of assets78.1% · 78.8%

Astrotech is growing faster than its size class, with revenue that swings more. Its own audited SEC figures.

The figures, as filed

Fiscal year end2026-06-30
Revenue$1M
Revenue, on the year−13.0%
Revenue, a year over the record1.2%
Operating margin−1548.5%
Operating margin, prior year−1404.6%
Net margin−1580.2%
Research and development$6M · 710.2% of revenue
Total debt—
Equity of assets78.9%
Return on equity−89.2%
Payout of profit—
Dividend per share—
Earnings per share$-8.49
Book value per share$9.51
Revenue per share$0.54
Shares outstanding1,700,000
Audited years read5

Peers: the median of 12 filers with $50M+ revenue in laboratory analytical instruments.

Classic signals · fiscal 2026Altman Z″ -38.52 distress zone 1968Piotroski F 3 of 9 middling 2000Beneish M -3.06 below the −1.78 line 1999Sloan accruals -4.1% earnings backed by cash 1996DuPont ROE -75.4% = margin -1580.2% × turns 0.04 × leverage 1.24

What a terminal subscription used to buy, a filing and arithmetic now give anyone. Published method, from the same filings. Display only: nothing here moves the range or its receipt. Why? →

Health HarborAstrotech sails as Old boat3 warning signs

Health watch · 12 monthsDirector or officer change ×2

Versus peersoperating margin −1548.5% vs a −1.0% median · revenue growth −13.0% vs 1.1% · cash beats 1% of its size class · growth beats 59% 12 laboratory analytical instruments filers

Trend · last year to this▼operating margin −1404.6% → −1548.5% · ▼revenue $1.0M → $0.9M · 5-year revenue: $0.9M · $0.8M · $1.7M · $1.0M · $0.9M

See all 14 laboratory analytical instruments companies on POPS4 sorted from the newest ship to the boat at the dock
#CompanyConditionOperating marginRevenue growthSales
1New shipAgilent TechnologiesANew ship21.3%6.7%$6.9B
2New shipIlluminaILMNNew ship18.6%−0.7%$4.3B
3New shipBrukerBRKRNew ship2.0%2.1%$3.4B
4Sound shipAvantorAVTRSound ship−3.8%−3.4%$6.6B
5Sound ship10x GenomicsTXGSound ship−9.5%5.2%$642.8M
6Weathered boatCytek BiosciencesCTKBWeathered boat−20.0%0.5%$201.5M
7Old boatSeerSEEROld boat−470.5%17.0%$16.6M
8Old boatAstrotechASTC · this companyOld boat−1548.5%−13.0%$0.9M
9Rotting at the dockBionano GenomicsBNGORotting at the dock−116.9%−7.4%$28.5M
10Rotting at the dockRapid Micro BiosystemsRPIDRotting at the dock−141.1%19.7%$33.6M
11Rotting at the dockScientific IndustriesSCNDRotting at the dock−156.1%5.4%$5.1M
12Rotting at the dockBioforce Nanosciences HoldingsBFNHRotting at the dock−261.8%9.0%$0.0M
13Rotting at the dockPacific Biosciences OF CaliforniaPACBRotting at the dock−346.2%3.9%$160.0M
14Rotting at the dockEyePointEYPTRotting at the dock−776.0%−27.5%$31.4M

From each company’s own POPS4 card. Green beats the industry median above, red trails it. Not a rating and not investment advice.

Sailing speed follows growth: 6.5% a year crosses the harbor in 61 seconds.

🌊 Visit the Bay →
The warning signs
  • Operating cash flow was negative
  • Operating loss a margin of -1548.5% in FY2026
  • Revenue is hard to predict its 80% range is ±77%

Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an operating loss; negative free cash flow outside regulated utilities; an 80% revenue range of ±25% or wider. A picture of the signs, not a rating and not investment advice.

Recent filings
Measured, not prophesiedSuccess tools: score it, compare it, see its fieldFour questions. Scored against the SEC filings of the companies in your field.

Try InstagramSpriteHokaDisneyGatoradee.l.f.

Each benchmark is the median of SEC filers in your industry code, from their own audited filings, read on the filing boards. Reporting, not investment advice.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets and no trading recommendations. Figures from the SEC’s own data · every filing · this page as JSON · Open in Excel (CSV) · Ten-year table (CSV) ·

1 · Follow

Follow their filings

Or tap watch on any row above. You get the company’s live filing feed and Edgar’s card. Nothing to sign up for.

On Bluesky: follow Edgar & Edgarette.

2 · Price it

A new leader’s rebrand and launch

Priced live by the same engine as our estimator, from the catalogue at wholesale.

Price the printing · Open the full estimator

✦ Build the kit yourself
3 · Confirm

Check it with Jenny

Most buyers check what they found, or what their AI found, with one person before they commit. That person is the principal.

Jenny Huang Goodman MPA MSc MHSA, Principal

Book a time info@pops4.com
Independence. Every range, flag and score on these boards is identical for everyone. Clients of POPS4 or Hako Shikin receive no different numbers, no earlier access and no say in what is published. The service lines shown beside each board describe work we do; they never change the data. For reviewers: Method · Terms of use · Status
Free · unsponsored · source-linked

Clean data. No ads. Not now, not later.

Nine boards reading every SEC filing the business day after it lands, from the settled SEC daily index, ten editorial desks publishing daily, an open endpoint other AIs can query, and a 70,000-product house behind all of it. This is the public record end of it.

Every row is a filing.Straight from the company's own SEC document, linked. Nothing written, nothing inferred.
Nobody is watching you read.No ad trackers, no cookies from us. Our page counts are cookieless.
One email, one job.Watch a company and we hold that address for the alert alone. One tap ends it. Never shared, never passed on.
The house pays for this.Corporate event programs, corporate supplies and branded merchandise, since 1997. That is what funds the desks, under the house's own vendor standards.
Free to reuse with credit · CC BY 4.0 · how the boards are built
Data & Disclosure Notice: Edgar and Edgarette are automated software. Every figure on this page is calculated by software from public filings made by companies and funds with the U.S. Securities and Exchange Commission (EDGAR) and is published without individual human review. The accuracy and completeness of those filings are the responsibility of the filers; reports can contain errors and can be amended. Figures are shown as filed and as of each filing's date, and this page may be corrected or updated without notice. Ranges, expected returns, rankings, boats and other measures are statistical descriptions of past filings, not ratings, price forecasts, company guidance or recommendations; past results do not guarantee future results. This is general information published for all readers, not advice tailored to any person's portfolio, needs or circumstances, and nothing here is financial, investment, actuarial, legal, tax or other professional advice. Actuaries and other professionals who use these figures remain responsible for reviewing them for reasonableness and consistency against the original filings and for disclosing their reliance on them. No company, fund or reinsurer pays to be included or ranked. Provided as is, without warranty of any kind. Not affiliated with or endorsed by the SEC or by any company, fund or reinsurer named. All trademarks remain the property of their owners.